Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 376

The DOI matches its Crossref record; 390 of the 390 references it cites were found in a registry or an index.

Blood biomarkers for the non-invasive diagnosis of endometriosis

Open access
Nisenblat, Vicki, Bossuyt, Patrick MM, Shaikh, Rabia, Farquhar, Cindy, Jordan, Vanessa, Scheffers, Carola S, Mol, Ben Willem J, Johnson, Neil, Hull, M Louise · 2016 · Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: About 10% of reproductive-aged women suffer from endometriosis, a costly chronic disease causing pelvic pain and subfertility. Laparoscopy is the gold standard diagnostic test for endometriosis, but is expensive and carries surgical risks. Currently, there are no non-invasive or minimally invasive tests available in clinical practice to accurately diagnose endometriosis. Although other reviews have assessed the ability of blood tests to diagnose endometriosis, this is the first review to use Cochrane methods, providing an update on the rapidly expanding literature in this field. OBJECTIVES: To evaluate blood biomarkers as replacement tests for diagnostic surgery and as triage tests to inform decisions on surgery for endometriosis. Specific objectives include:1. To provide summary estimates of the diagnostic accuracy of blood biomarkers for the diagnosis of peritoneal, ovarian and deep infiltrating pelvic endometriosis, compared to surgical diagnosis as a reference standard.2. To assess the diagnostic utility of biomarkers that could differentiate ovarian endometrioma from other ovarian masses. SEARCH METHODS: We did not restrict the searches to particular study designs, language or publication dates. We searched CENTRAL to July 2015, MEDLINE and EMBASE to May 2015, as well as these databases to 20 April 2015: CINAHL, PsycINFO, Web of Science, LILACS, OAIster, TRIP, ClinicalTrials.gov, DARE and PubMed. SELECTION CRITERIA: We considered published, peer-reviewed, randomised controlled or cross-sectional studies of any size, including prospectively collected samples from any population of reproductive-aged women suspected of having one or more of the following target conditions: ovarian, peritoneal or deep infiltrating endometriosis (DIE). We included studies comparing the diagnostic test accuracy of one or more blood biomarkers with the findings of surgical visualisation of endometriotic lesions. DATA COLLECTION AND ANALYSIS: Two authors independently collected and performed a quality assessment of data from each study. For each diagnostic test, we classified the data as positive or negative for the surgical detection of endometriosis, and we calculated sensitivity and specificity estimates. We used the bivariate model to obtain pooled estimates of sensitivity and specificity whenever sufficient datasets were available. The predetermined criteria for a clinically useful blood test to replace diagnostic surgery were a sensitivity of 0.94 and a specificity of 0.79 to detect endometriosis. We set the criteria for triage tests at a sensitivity of ≥ 0.95 and a specificity of ≥ 0.50, which 'rules out' the diagnosis with high accuracy if there is a negative test result (SnOUT test), or a sensitivity of ≥ 0.50 and a specificity of ≥ 0.95, which 'rules in' the diagnosis with high accuracy if there is a positive result (SpIN test). MAIN RESULTS: We included 141 studies that involved 15,141 participants and evaluated 122 blood biomarkers. All the studies were of poor methodological quality. Studies evaluated the blood biomarkers either in a specific phase of the menstrual cycle or irrespective of the cycle phase, and they tested for them in serum, plasma or whole blood. Included women were a selected population with a high frequency of endometriosis (10% to 85%), in which surgery was indicated for endometriosis, infertility work-up or ovarian mass. Seventy studies evaluated the diagnostic performance of 47 blood biomarkers for endometriosis (44 single-marker tests and 30 combined tests of two to six blood biomarkers). These were angiogenesis/growth factors, apoptosis markers, cell adhesion molecules, high-throughput markers, hormonal markers, immune system/inflammatory markers, oxidative stress markers, microRNAs, tumour markers and other proteins. Most of these biomarkers were assessed in small individual studies, often using different cut-off thresholds, and we could only perform meta-analyses on the data sets for anti-endometrial antibodies, interleukin-6 (IL-6), cancer antigen-19.9 (CA-19.9) and CA-125. Diagnostic estimates varied significantly between studies for each of these biomarkers, and CA-125 was the only marker with sufficient data to reliably assess sources of heterogeneity.The mean sensitivities and specificities of anti-endometrial antibodies (4 studies, 759 women) were 0.81 (95% confidence interval (CI) 0.76 to 0.87) and 0.75 (95% CI 0.46 to 1.00). For IL-6, with a cut-off value of > 1.90 to 2.00 pg/ml (3 studies, 309 women), sensitivity was 0.63 (95% CI 0.52 to 0.75) and specificity was 0.69 (95% CI 0.57 to 0.82). For CA-19.9, with a cut-off value of > 37.0 IU/ml (3 studies, 330 women), sensitivity was 0.36 (95% CI 0.26 to 0.45) and specificity was 0.87 (95% CI 0.75 to 0.99).Studies assessed CA-125 at different thresholds, demonstrating the following mean sensitivities and specificities: for cut-off > 10.0 to 14.7 U/ml: 0.70 (95% CI 0.63 to 0.77) and 0.64 (95% CI 0.47 to 0.82); for cut-off >

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd012179

Cites

390 of 390 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 390 references

Research works printed but not linked: 61

  1. Calienno, 2008, MCP-1 and IL-8 in serum and ectopic endometrium in women with endometriosis, Italian Journal of Gynaecology and Obstetrics, 20, 12
  2. Ferreira, 1994, Assessement of serum concentration CA-125 in the diagnosis of endometriosis, Jornal Brasileiro de Gynecologia, 104, 311
  3. Goluda, 1998, The concentration of exfoliative adhesion molecules (ICAM-1 and E-Selectin) in serum and peritoneal fluid of women with endometriosis, Ginekologia Polska, 69, 1175
  4. Lamp, 2012, Survivin promoter polymorphisms and autoantibodies in endometriosis, Journal of Reproductive Immunology, 96, 95, 10.1016/j.jri.2012.10.001 · doi:10.1016/j.jri.2012.10.001
  5. Lin, 2005, Determination of interleukine-16 levels in peritoneal fluid and serum of women with endometriosis, Zhejiang Daxue Xuebao (Yixueban) [Journal of Zhejiang University (Medical Sciences)], 34, 260-2. Chinese
  6. Liu, 2009, Establishment of endometriosis diagnostic model using plasma protein profiling, Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics and Gynecology], 44, 601-4. Chinese
  7. Markham, 1997, Blood and peritoneal fluid concentrations of TNFalpha and RANTES in patients with and without endometriosis, Australian Journal of Medical Science, 18, 116
  8. Matveeva, 1990, Immunological studies of peripheral blood in patients with external genital endometriosis and infertility, Akusherstvo i Ginekologiia, 8, 48
  9. Szczepaska, 2001, Antizona and antisperm antibodies in women with endometriosis and/or infertility, Fertility & Sterility, 75, 97, 10.1016/S0015-0282(00)01667-8 · doi:10.1016/s0015-0282(00)01667-8
  10. Wei, 2005, Leptin levels and infertile patients with endometriosis, Zhongnan Daxue Xuebao (Yixue Ban) [Journal of Central South University (Medical Sciences)], 30, 487-8. Chinese
  11. Yang, 1994, Value of CA125 (carbon hydrate tumor-associated antigen) and endometrial antibodies for the detections of endometriosis, Zhonghua Fuchanke Zazhi [Chinese Journal of Obstetrics and Gynecology], 29, 147-149, 189. C
  12. Zhang, 2005, Measurements of interleukin-18 in peritoneal fluid and serum of patients with endometriosis, Zhongnan Daxue Xuebao (Yixue Ban) [Journal of Central South University (Medical Sciences)], 30, 731-2. Chinese
  13. Zhang, 2006, Soluble intercellular adhesion molecule 1 in serum and peritoneal fluid on patients with endometriosis, Wuhan Yike Daxue Xuebao (Yixueban) [Medical Journal of Wuhan University], 27, 97-9. Chinese
  14. Abdallah, 2006, Matrix metalloproteinase-9 activity in the plasma of patients after surgical resection of endometriomas, Fertility and Sterility, 85, 1847, 10.1016/j.fertnstert.2005.11.043 · doi:10.1016/j.fertnstert.2005.11.043
  15. Arjona Berral, 1996, Serum CA 125 and CA 19.9 levels in the diagnosis of patients with suspected endometriosis, Revista Espanola de Medicina Nuclear, 15, 71
  16. Barbieri, 1987, CA-125 and endometriosis, Contributions to Gynecology and Obstetrics, 16, 103, 10.1159/000414854 · doi:10.1159/000414854
  17. Basta, 2009, Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma, Neuroendocrinology Letters, 30, 91
  18. Bianchi, 2003, Correlation between CA-125 marker with the presence and severity of pelvic endometriosis, Revista Medica de Chile, 131, 367
  19. Brinton, 1996, Endometriosis: identification by carbonic anhydrase autoantibodies and clinical features, Annals of Clinical and Laboratory Science, 26, 409
  20. Cai, 2005, Changes of serum epithelial neutrophil-activating peptide-78 in patients with endometriosis, Di 1 Junyi Daxue Xuebao [Academic Journal of the First Medical College of PLA], 25, 464-5. Chinese
  21. Dawood, 1988, Plasma and peritoneal fluid levels of CA 125 in women with endometriosis, American Journal of Obstetrics and Gynecology, 159, 1526, 10.1016/0002-9378(88)90588-1 · doi:10.1016/0002-9378(88)90588-1
  22. Ejzenberg, 2013, Measurement of serum and peritoneal levels of amyloid protein A and their importance in the diagnosis of pelvic endometriosis, Journal of Reproductive Medicine, 58, 411
  23. Galo, 2005, TNF-alpha serum levels in women with endometriosis: Prospective clinical study, Ceska Gynekologie, 70, 286
  24. Gebel, 1995, Differential expression of VLA beta 1 (CD29) on monocytes from patients with endometriosis, American Journal of Reproductive Immunology, 34, 317, 10.1111/j.1600-0897.1995.tb00958.x · doi:10.1111/j.1600-0897.1995.tb00958.x
  25. Gunev, 1981, FSH, LH, estradiol and testosterone studies of the blood serum in endometriosis externa, Akusherstvo i Ginekologiia, 20, 312
  26. He, 1993, Prolactin secretion in patients with endometriosis and its relationship to luteal phase defect and infertility, Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics and Gynecology], 28, 14-7. Chinese
  27. Hompes, 1996, Serum CA-125 concentrations during midfollicular phase, a clinically useful and reproducible marker in diagnosis of advanced endometriosis, Clinical Chemistry, 42, 1871, 10.1093/clinchem/42.11.1871 · doi:10.1093/clinchem/42.11.1871
  28. Hrycek, 1996, Selected immunologic markers for evaluation of peripheral blood in patients with internal endometriosis, Wiadomosci lekarskie, 49, 10
  29. Jedryka, 2001, E-cadherin in the serum and the peritoneal fluid of women with endometriosis, Ginekologia Polska, 72, 418
  30. Kadija, 2012, The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis, International Journal of Gynecological Cancer, 22, 238, 10.1097/IGC.0b013e318234f852 · doi:10.1097/igc.0b013e318234f852
  31. Kobayashi, 1987, Usefulness of measurement of serum CA125 levels in diagnosing and treating endometriosis, Nippon Sanka Fujinka Gakkai Zasshi - Acta Obstetrica et Gynaecologica Japonica, 39, 1054
  32. Kondera-Anasz, 2004, Concentrations of neopterin and interleukin-10 in peritoneal fluid and in serum of women with endometriosis, Pteridines, 15, 20, 10.1515/pteridines.2004.15.1.20 · doi:10.1515/pteridines.2004.15.1.20
  33. Kralickova, 2007, Association of the leukemia inhibitory factor gene mutation and the antiphospholipid antibodies in the peripheral blood of infertile women, Folia Microbiologica, 52, 543, 10.1007/BF02932117 · doi:10.1007/bf02932117
  34. Leggieri, 2014, Is HE4 a useful endometrioma marker?, European Journal of Gynaecological Oncology, 35, 438
  35. Leng, 2002, Serum levels of soluble intercellular molecule 1 (sICAM-1) in endometriosis, Zhonghua Yixue Zazhi [Chinese Medical Journal], 82, 189-90. Chinese
  36. Li, 2000, Evaluation of tumor necrosis factor-alpha and interleukin-6 levels in serum and peritoneal fluid of patients with endometriosis, Zhonghua Fuchanke Zazhi [Chinese Journal of Obstetrics and Gynecology], 35, 166-8. Chinese
  37. Liu, 2013, The expression and role of oxidative stress markers in the serum and follicular fluid of patients with endometriosis, Clinical and Experimental Obstetrics & Gynecology, 40, 372
  38. Luo, 2005, Evaluation of tumor necrosis factor-alpha and tumor necrosis factor-beta in serum of patients with endometriosis, Zhongnan Daxue Xuebao (Yixue Ban) [Journal of Central South University (Medical Sciences)], 30, 304-6. Chinese
  39. Markham, 1997, The measurement of tumour necrosis factor alpha in patients with endometriosis, Australian Journal of Medical Science, 18, 56
  40. Nalbanski, 2008, The use of biochemical markers in diagnosis of endometriosis, Akusherstvo i Ginekologiia, 47, 19
  41. Ota, 1990, Evaluation of autoantibody and CA125 in the diagnosis of endometriosis or adenomyosis, Medical Science Research, 18, 309
  42. Ota, 1991, Autoantibody sensitivity in the diagnosis of endometriosis and adenomyosis, Japanese Journal of Fertility and Sterility, 36, 799
  43. Ozasa, 1987, Progesterone increases serum CA-125 in endometriosis, Fertility and Sterility, 47, 699, 10.1016/S0015-0282(16)59125-0 · doi:10.1016/s0015-0282(16)59125-0
  44. Perwira I Comparison of TNF-alpha and IL-6 between the blood and peritoneal fluid in patients with endometriosis Thesis: Universitas Gadjah Mada, Yogyakarta 2009
  45. Ramos IML Podgaec S Evaluation of CA-125 and CD-23 soluble in patients with pelvic endometriosis Biblioteca Digitais de Teses e Dissertações da USP 2011 · DOI
  46. Szyllo, 2001, Evaluation of the generation of interleukin-10 by peripheral blood lymphocytes in women with endometriosis, Ginekologia Polska, 72, 437
  47. Takahashi, 1987, CA 125 antigen is an effective diagnostic for external endometriosis, Gynecologic and Obstetric Investigation, 23, 257, 10.1159/000298869 · doi:10.1159/000298869
  48. Takahashi, 1988, Clinical usefulness of determination of CA 125 levels in the serum and menstrual blood, Gynecologic and Obstetric Investigation, 26, 63, 10.1159/000293674 · doi:10.1159/000293674
  49. Tanaka, 2000, Anti-endometrial IgM autoantibodies in endometriotic patients: a preliminary study, Clinical and Experimental Obstetrics & Gynecology, 27, 133
  50. Tsao, 2007, Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis, Journal of Clinical Laboratory Analysis, 21, 193, 10.1002/jcla.20168 · doi:10.1002/jcla.20168
  51. Wild, 1991, F(ab')2 segment is the active component of immunoglobulin G autoantibody generation in patients with endometriosis, Fertility and Sterility, 56, 900, 10.1016/S0015-0282(16)54662-7 · doi:10.1016/s0015-0282(16)54662-7
  52. Wild, 1992, Detection of antiendometrial antibodies in patients with endometriosis: methodological issues, Fertility and Sterility, 58, 518, 10.1016/S0015-0282(16)55255-8 · doi:10.1016/s0015-0282(16)55255-8
  53. Wojcik-Krowiranda, 2010, Usefulness of determination of CA125 concentration as a marker for ovarian tumours with special consideration of ovarian endometriotic cysts, Przeglad Menopauzalny, 9, 362
  54. Zhu, 2007, Measurement of CA125 in serum and ovarian cyst fluid of patients with endometriosis and its clinical significance, Xi'an Jiaotong Daxue Xuebao (Yexueban) [Journal of Xi'an Jiaotong University (Medical Sciences)], 28, 687-9. Chinese
  55. Adamson GD Endometriosis Fertility Index (EFI): the new validated endometriosis staging system Art and science of endometriosis. Proceedings of the Tenth World Congress on Endometriosis; 2008 March 11-14; Melbourne (Vic) 2008
  56. Bossuyt PM Leeflang MM Chapter 6: Developing Criteria for Including Studies. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.methods.cochrane.org/sdt/handbook-dta-reviews
  57. De Vet HCW Eisinga A Riphagen II Aertgeerts B Pewsner D Chapter 7: Searching for Studies. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.methods.cochrane.org/sdt/handbook-dta-reviews
  58. Matalliotakis, 2008, Suggested markers for the diagnosis of endometriosis, Current Women's Health Reviews, 4, 25, 10.2174/157340408783572042 · doi:10.2174/157340408783572042
  59. Segen, 2006, McGraw-Hill Concise Dictionary of Modern Medicine
  60. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
  61. Olendorf, 2011, The Gale Encyclopedia of Medicine (5 volume set)

Cited by

See all 376

Metadata

Authors
Nisenblat, V., Bossuyt, P. M., Shaikh, R., Farquhar, C., Jordan, V., Scheffers, C. S., Mol, B. W. J., Johnson, N., & Hull, M. L.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2016-05-01
Volume
2016
Issue
5
Pages
CD012179-CD012179
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W2410974791
Cited by
376
References
390
FWCI
31.09
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood biomarkers for the non-invasive diagnosis of endometriosis. https://app.cochat.ai/papers/10.1002/14651858.cd012179
The paper
Nisenblat, V., Bossuyt, P. M., Shaikh, R., Farquhar, C., Jordan, V., Scheffers, C. S., Mol, B. W. J., Johnson, N., & Hull, M. L. (2016). Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd012179

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.